Next-generation insulin developer Thermalin Diabetes has received a $4.5 million grant from the National Institutes of Health to continue development of its insulin analogs. The grant is expected to fund Cleveland-based Thermalin through the filing of an investigational new drug (IND) application for a rapid-acting insulin analog drug candidate, CEO Rick Berenson said.
CLEVELAND, Ohio — PNC Bank is building a $5 million resource center in Cleveland’s Fairfax neighborhood to provide educational programs and to cultivate the area’s rich heritage. “We’re very proud of this unique collaboration,” said regional PNC manager Paul Clark, who on Wednesday announced creation of the PNC Fairfax Connection during a gathering at the [...]
PROVIDENCE – Leaders from three prominent nonprofit technology venture groups said Tuesday that Rhode Island is well-positioned to expand its creative economy with sustained investments from the government, research institutions and businesses. The three organizations – Cleveland Clinic Innovation in Ohio, Innovation Works in Pittsburgh and University City Science Center in Philadelphia – have all [...]
CLEVELAND, Ohio — The Cleveland Clinic is pairing with New York’s North Shore-Long Island Jewish Health System to share its expertise in developing and marketing medical innovations.The deal, the value of which is not being disclosed, is the second such collaboration the Clinic has formed and possibly the beginning of a “national innovation alliance,” said [...]
Juventas Therapeutics Inc. of Cleveland has raised $12 million in equity financing that it will use to finance Phase II clinical trials of a drug designed to recruit the body’s stem cells to repair damaged tissue.
The $943,000 in financing for Cincinnati-area IschemiaCare comes through the Innovation Ohio Loan Fund program, which is aimed at helping companies in the state develop next-generation products.IschemiaCare‘s project funded through the loan is expected to create 22 jobs, according to the Ohio Department of Development. The state recently has stopped providing anything beyond the most [...]
Biomarker test-maker Cleveland HeartLab has closed an $18.4 million series B round of funding, which was led by two Boston-area investors. The size of the round is a testament to the explosive growth that the young company has achieved in less than two years of existence after being spun out from Cleveland Clinic — and [...]
A regenerative medicine spinoff from the Cleveland Clinic and Juventas Therapeutics that’s developing a wound healing treatment has closed a $3.4 million series A round of investment. SironRX Therapeutics will use the funding to begin clinical trials of its wound therapy technology and hire senior management and clinical staff, CEO Rahul Aras said.
ImageIQ is partnering with the National Center for Regenerative Medicine (NCRM) at Case Western Reserve University (CWRU), Cleveland Clinic, and the Cleveland Cord Blood Center (CCBC) to develop customized image acquisition and analysis software. The deal is part of the three-year biomedical technology and innovation project through an Ohio Third Frontier Program grant.
ImageIQ, Inc., announced today that the National Aeronautics and Space Administration’s Ames Research Center, Moffett Field, Calif., and The Midura Laboratory at the Lerner Research Institute (LRI) of Cleveland Clinic have selected ImageIQ to assist in their study of space flight-induced vascular alterations in the lower leg. ImageIQ will provide customized image acquisition and analysis [...]
Explorys, Inc. announced today that St. Joseph Health System (SJHS) is the most recent major integrated health system to utilize the Explorys network. Now spanning coast-to-coast in the U.S., Explorys collects, standardizes, and aggregates large-scale clinical data to enable healthcare leaders to identify and measure outcomes, correlations, trends, and metrics that lead to better delivery [...]
ImageIQ, Inc., the Imaging Contract Research Organization developed through Cleveland Clinic Innovations, announces today that The Griffith Laboratory at the Massachusetts Institute of Technology and its partner laboratory within the Singapore-MIT Alliance for Research & Technology(SMART) have selected ImageIQ to provide customized image analysis and software engineering services for several of their large-scale research projects. [...]
If a Cleveland biomedical company has its way, there soon will be. Renovo Neural, a spinoff of the Cleveland Clinic, is currently helping pharmaceutical companies test new MS drugs by providing exclusive and innovative assays that analyze the potency of promising new drugs to reverse the MS process.
A phase 1 clinical trial has shown that Juventas Therapeutics‘ regenerative medicine therapy provides clinical benefit to heart failure patients. Phase 1 trials generally focus on safety, so the indication of clinical benefit is an encouraging sign for Cleveland-based Juventas. “We are excited to see strong signs of efficacy across multiple clinical parameters,” CEO Rahul [...]
Bridge Investment Fund recently scored its biggest win — in the eyes of job-creation-conscious local investors, at least — when Israel-based portfolio company IceCure decided to establish its U.S. headquarters in Cleveland.
Cleveland Clinic spinoff Renovo Neural is looking to help pharmaceutical companies create a better drug to treat multiple sclerosis, a disease that attacks the central nervous system and can lead to paralysis. Rather than develop a drug itself, Renovo’s focus is to do preclinical development work for bigger drug firms, screening small molecules to discover [...]
Israeli device company IceCure Medical has chosen Cleveland to be its U.S. headquarters, a move the company’s CEO hinted at in February. The company plans to open its U.S. headquarters at the Cleveland Clinic-led Global Cardiovascular Innovation Center campus on June 1, according to a statement from IceCure.
Wound therapy startup SironRX Therapeutics has made a first close on a series A round of investment that’s expected to reach $3 million. SironRx, built on technology pioneered at Cleveland Clinic, plans to use the funding to begin human trials, which could start around the end of the year, said CEO Rahul Aras, former director [...]
CLEVELAND–(BUSINESS WIRE)–ImageIQ, an imaging contract research organization (CRO) specializing in advanced medical image acquisition, analysis and visualization, today announced the company’s spin-out of technology and expertise developed at Cleveland Clinic Innovations. Concurrent with the formation of the company, Cleveland Clinic Innovations announces the appointment of Timothy Kulbago as President and CEO of ImageIQ.
Cleveland Clinic spinoff Explorys Inc. has raised $11.5 million that should help the data technology firm double the size of its staff by the end of 2011, said Charlie Lougheed, president and chief technology officer of the Cleveland company. The investment was led by Austin Ventures of Austin, Texas, and Foundation Medical Partners of Rowayton, [...]
Juventas Therapeutics, a clinical-stage regenerative medicine company developing novel therapies for cardiovascular disease, announces that it has successfully completed its Phase I clinical trial evaluating the safety and preliminary efficacy of JVS-100 for treatment of patients with heart failure. Complete results from the trial will be reported at the 2011 Annual Meeting for the American [...]
Thermalin Diabetes, a JumpStart Ventures portfolio company, recently closed $2.85 million in Series A investments, paving the way to the further development of short, medium and long lasting insulin analogs by Case Western Reserve Medical School Dr. Michael A. Weiss.
The announcement includes a second $250,000 investment from JumpStart, and exceeds Thermalin’s original target by $1 [...]
Creganna-Tactx Medical has announced the opening of a new office at Cleveland Clinic’s, Global Cardiovascular Innovation Centre (GCIC). The company was invited to open an office in the new incubator to support companies commercializing innovative medical device technology. The office will provide product development support to early stage companies and also link Creganna-Tactx’s customers to [...]
Innoheart and genae today announced a shared vision on integrated research services, allowing the acceleration of clinical research and development of biomedical devices and therapies. The alliance will allow both organizations to drive new growth opportunites globally and transform translational clinical research, reducing costs and accelerating market entry for new biomedical devices and therapies.
Farm, a company that specializes in product development for medical device firms, is opening an office at the Cleveland Clinic’s new cardiovascular technology incubator
